SENSEX 78,183.36
+ 255.21
NIFTY 24,398.90
+ 81.75
CRUDEOIL 7,870.00
Strides Pharma Science Q1 PAT rises 56.7% to ₹165.5 cr
Strides Pharma Science Ltd on Friday reported a 56.7 per cent rise in profit after tax at Rs 165.5 crore in the first quarter ended June 30, on the back of strong growth in markets excluding the US.
TL;DRAI
Strides Pharma Q1 PAT up 56.7% to ₹165.5 crore; ex-US markets grew 17% YoY, offsetting 4% US slowdown. Portfolio diversification is de-risking exposure; EBITDA +5% YoY despite ₹13.1 crore geopolitical headwind demonstrates operational control.
283 words~1 min read
